Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Shares in fully-listed Victrex clipped ahead by 7p in early dealings today after the small cap chemicals concern cheered investors with an upbeat first half trading result. James Crux reports.
Victrex (VCT) is the only maker of PEEKa polymer, a high performance thermoplastic which is used in the industrial, automotive, aerospace, medical and food industries. The company has manufacturing plants and research facilities in the UK, and sales and distribution centres serving more than 30 countries worldwide.
In today's bullish trading update for the first half to March, Victrex said demand had continued at the increased levels seen at the start of the calendar year, and reported first half sales volumes of about 550 tonnes. This means the company should unveil sales volumes of about 1,200 tonnes for the current year to September, still lower than previous expectations and also lower than volumes in 2001. Interim figures are due out on 11 June.
In December, the group's 2001 preliminary figures showed sales volumes up 21 per cent at 1,603 tonnes in a year of record sales and profits. Turnover improved 23 per cent to £72.1 million, and profit before tax put on 40 per cent at £22.3 million. Investors also saw a 10 per cent rise in their total dividend at 6.7p. Nevertheless, at the time the board flagged up falling first quarter sales as business was hit by the global downturn.
Before today's bullish statement, house broker Cazenove was forecasting £20.3 million of pre-tax profit, giving 18.4p of earnings for the current year. And with the shares sparking up by 7p to 323.5p on the news, against 52-week highs and lows of 402.5p and 245.5p, Victrex is trading in line with the 17.47 sector average, on about 17.6 times 2002 earnings. Not cheap, but the outlook appears much improved.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.